New targeted drug trial offers hope for Tough-to-Treat breast cancer
Disease control
Not yet recruiting
This study tests an experimental drug called ARX788 for people with advanced HER2-low breast cancer that has spread or cannot be surgically removed. The drug is designed to deliver a cancer-killing toxin directly to tumor cells. Researchers will measure how well tumors shrink, ho…
Phase: PHASE2 • Sponsor: Laura Huppert, MD, BA • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC